Silver Gorilla

201 Followers
307 Following
452 Posts
#MSChat. Secondary Progressive #MultipleSclerosis. #ATA188 trial participant. #Disability Advocate. #StreetPhotography #Wheelocks #Latin #Books #NonFiction #Jung SilverGorilla2.com

@Lomelindi12 @OcreJulia @Samantha72 @SilverGorilla2

I remember a good newsletter from dr G. Giovannoni about lymphopenia, can't find it, but I have a translation in french and 1 scientific article:

https://www.forseps.org/t3106-lymphocytes-lymphopenie?highlight=Lymphop%C3%A9nie#33738

https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002685

Lymphopenia according to WHO

 DegrĂ© 0> = 1000 / mm3

 DegrĂ© 1 = 800-999 / mm3

 DegrĂ© 2 = 500-799 / mm3

 DegrĂ© 3 = 200-499 / mm3

 DegrĂ© 4 <200 / mm3

Sorry having the flu and high temperature, can't do more at the moment 🌡️🤒

Lymphopénie - Lymphocytes/ lymphopénie?

Lymphopénie Bonsoir, Je viens de lire cet article du 27 mars 2020, par le prof. neuro G. Giovannoni, qui mentionne, dans la situation pandémique liée au SARS-Co

www.forseps.org
Merry Christmas from your friends at Wicked Good Books.

That thing where you spend a week "reorganising" your bookshelves ie sorting books into a giveaway pile that you can't bear to actually give away plus re-reading fabulous old favourites you'd forgotten you had.

The shelves remain disorderly, but I have an even larger TBR pile, and am too happy to care.

Scientists tie third clinical trial death to experimental Alzheimer's drug | Science | AAAS #medicine https://www.science.org/content/article/scientists-tie-third-clinical-trial-death-experimental-alzheimer-s-drug
Scientists tie third clinical trial death to experimental Alzheimer’s drug

Amid lobbying for lecanemab’s approval, a newly revealed death adds to doubts about safety of antiamyloid antibody

Light Therapy Found to Relieve Fatigue Syndrome in Multiple Sclerosis - Neuroscience News

Neuroscience News provides research news for neuroscience, neurology, psychology, AI, brain science, mental health, robotics and cognitive sciences.

Neuroscience News

Here’s my #introduction.

I’m Christie. I’m #queer and live with my wife of several years in Portland, OR. We have an older English bulldog named Bertie and a younger grey and white tabby cat named Ursa Minor.

My day job is in #InfrastructureEngineering with a big tech company. I’m the technical lead for a team that provides a virtual compute platform globally for our business unit. I’m really good at it, in terms of people, tech, and process.

I used to be quite heavily involved in Open Source and tech community organizing. Less so now, mostly because maintaining my health takes a lot of energy.

I have both #MultipleSclerosis and #SjögrensSyndrome. This means the pandemic isn’t over for our family. We still mask in public and limit outings to essentials. I’m pretty angry at how our government has failed to anything but the barest minimum to mitigate COVID-19 spread and impact.

For fun I like to tinker with computers, make art with #Photography and #WaterColor, and play #TabletopGames as well as #VideoGames. #Civilization and #Skyrim are two of my fav video games. I love #MagicTheGathering, tho it’s hard to keep up these days. TV brings me a lot of comfort and I’m a big fan of rewatches. Podcasts about TV? Mmm yeah. Tasty.

I’m interested in #Antifascist organizing, #MutualAid and #CommunityDefense. I’d like to figure out how to be in community in ways that work with my disabilities.

@gelleri
da ich durch meine #multipleSclerosis selbst erfahrungen mit atypischen Vitamindosierungen habe muss iich sagen das der Artikel ffĂĽr uns Chroniker leider uns mehr schadet als nĂĽtzlich ist

A 12-month, Open-label, Prospective, Multicenter, Interventional, Single-arm Study Assessing the Efficacy and Safety of Ofatumumab 20 mg Subcutaneous (s.c.) Injection in Relapsing Multiple Sclerosis (RMS) Patients in China

https://www.novartis.com//clinicaltrials/study/nct05199571

#MSchat #Neurology #MultipleSclerosis #ClinicalTrial

Study of Efficacy and Safety of Ofatumumab in Relapsing Multiple Sclerosis (RMS) Patients in China

A 12-month, Open-label, Prospective, Multicenter, Interventional, Single-arm Study Assessing the Efficacy and Safety of Ofatumumab 20 mg Subcutaneous (s.c.) Injection in Relapsing Multiple Sclerosis (RMS) Patients in China

Novartis Recruiting Clinical Trials

Humoral efficacy of the third SARS-CoV-2 vaccine dose in Multiple Sclerosis subjects undergoing different disease-modifying therapies

It remains unclear how vaccine doses and combinations of vaccination and infection affect the magnitude and quality of immune responses, particularly against novel SARS-CoV-2 variants in subjects with immune-related disorders. We evaluated t ...

https://www.msard-journal.com/article/S2211-0348(22)00875-6/fulltext

#MSchat #Neurology #MultipleSclerosis